Biomarker-based prediction of sinus rhythm in atrial fibrillation patients: the EAST-AFNET 4 biomolecule study
Low concentrations of ANGPT2, BMP10, and NT-proBNP identify patients with AF who are likely to attain sinus rhythm during follow-up. The predictive ability of NT-proBNP is attenuated in patients receiving rhythm control.
Authors
- Stéphane Hatem (ORCID: https://orcid.org/0000-0002-9790-0755)
- Lars Eckardt (ORCID: https://orcid.org/0000-0002-3735-8503)
- A. John Camm (ORCID: https://orcid.org/0000-0002-2536-2871)
- Eduard Guasch (ORCID: https://orcid.org/0000-0003-4238-5319)
- Andreas Rillig (ORCID: https://orcid.org/0000-0003-3457-0936)
- Moritz F. Sinner (ORCID: https://orcid.org/0000-0002-6660-796X)
- Andreas Goette (ORCID: https://orcid.org/0000-0002-8223-7209)
- Günter Breithardt (ORCID: https://orcid.org/0000-0001-7574-8900)
- Katrin Borof
- Tanja Zeller (ORCID: https://orcid.org/0000-0003-3379-2641)
- Vaishnavi Ameya Murukutla (ORCID: https://orcid.org/0000-0001-9455-3391)
- Ulrich Schotten (ORCID: https://orcid.org/0000-0003-1532-3315)
- Paulus Kirchhof (ORCID: https://orcid.org/0000-0002-1881-0197)
- Laura C. Sommerfeld (ORCID: https://orcid.org/0000-0001-9837-8770)
- Larissa Fabritz (ORCID: https://orcid.org/0000-0002-9241-1733)
- Lluı́s Mont (ORCID: https://orcid.org/0000-0002-8115-5906)
- Andreas Metzner (ORCID: https://orcid.org/0000-0002-6818-6396)
- Antonia Zapf (ORCID: https://orcid.org/0000-0002-8467-0508)
- Julius Obergassel (ORCID: https://orcid.org/0000-0002-3905-0203)
- Silke van Elferen
- Victor Roth Cardoso (ORCID: https://orcid.org/0000-0002-9588-6304)
- Winnie Chua (ORCID: https://orcid.org/0000-0002-6747-8813)
- Ursula‐Henrike Wienhues‐Thelen
- Georgios V. Gkoutos (ORCID: https://orcid.org/0000-0002-2061-091X)
- Renate B. Schnabel (ORCID: https://orcid.org/0000-0001-7170-9509)
- Harry J.G.M. Crijns (ORCID: https://orcid.org/0000-0003-1073-5337)
- Christoph Al-Taie (ORCID: https://orcid.org/0000-0001-7088-3943)
Institutions
- Roche (Switzerland) (CH)
- European Union (BE)
- Universität Hamburg (DE)
- St George's, University of London (GB)
- Maastricht University Medical Centre (NL)
- Maastricht University (NL)
- Sorbonne Université (FR)
- Roche Pharma AG (Germany) (DE)
- Assistance Publique – Hôpitaux de Paris (FR)
- University Hospital Münster (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Atrial Fibrillation NETwork (DE)
- Hospital Clínic de Barcelona (ES)
- Pitié-Salpêtrière Hospital (FR)
- German Centre for Cardiovascular Research (DE)
- St. Vincenz-Krankenhaus Limburg (DE)
- Health Data Research UK (GB)
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
- Universitat de Barcelona (ES)
- University of Birmingham (GB)
- Ludwig-Maximilians-Universität München (DE)
- Otto-von-Guericke-Universität Magdeburg (DE)
Publication Details
- Journal
- European Heart Journal
- Published
- 2024-08-31
- DOI
- https://doi.org/10.1093/eurheartj/ehae611
- Citations
- 25
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 10.05
Funders
- Pfizer
- Sanofi
- Boston Scientific Corporation
- Deutsches Zentrum für Herz-Kreislaufforschung
- Kompetenznetz Vorhofflimmern
- British Heart Foundation
- European Commission
- Deutsche Forschungsgemeinschaft
- Fondation Leducq
- Bundesministerium für Bildung und Forschung
- Hartstichting
- Universität Hamburg
- Deutsche Herzstiftung
- Johnson and Johnson
- St. Jude Medical
- HORIZON EUROPE Framework Programme
- H2020 European Research Council